Division of Nephrology, Bone and Mineral Metabolism, Department of Internal Medicine, University of Kentucky, Lexington, Kentucky.
Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, Michigan.
Kidney360. 2020 Dec 14;2(2):371-384. doi: 10.34067/KID.0004912020. eCollection 2021 Feb 25.
Continuous RRT (CRRT) is the preferred dialysis modality for solute management, acid-base stability, and volume control in patients who are critically ill with AKI in the intensive care unit (ICU). CRRT offers multiple advantages over conventional hemodialysis in the critically ill population, such as greater hemodynamic stability, better fluid management, greater solute control, lower bleeding risk, and a more continuous (physiologic) approach of kidney support. Despite its frequent use, several aspects of CRRT delivery are still not fully standardized, or do not have solid evidence-based foundations. In this study, we provide a case-based review and recommendations of common scenarios and interventions encountered during the provision of CRRT to patients who are critically ill. Specific focus is on initial prescription, CRRT dosing, and adjustments related to severe hyponatremia management, concomitant extracorporeal membrane oxygenation support, dialysis catheter placement, use of regional citrate anticoagulation, and antibiotic dosing. This case-driven simulation is made as the clinical status of the patient evolves, and is on the basis of step-wise decisions made during the care of this patient, according to the specific patient's needs and the logistics available at the corresponding institution.
连续性肾脏替代治疗(CRRT)是 ICU 中合并急性肾损伤的危重症患者进行溶质管理、酸碱平衡稳定和容量控制的首选透析方式。与危重症人群中的传统血液透析相比,CRRT 具有多项优势,例如更好的血流动力学稳定性、更好的液体管理、更好的溶质控制、更低的出血风险以及更连续(生理)的肾脏支持方式。尽管 CRRT 频繁使用,但在危重症患者中提供 CRRT 的几个方面仍未完全标准化,或者没有坚实的循证基础。在这项研究中,我们提供了一个基于病例的综述,并对 CRRT 治疗过程中常见的情况和干预措施提出了建议。重点关注初始处方、CRRT 剂量以及与严重低钠血症管理、同时进行的体外膜氧合支持、透析导管放置、局部枸橼酸抗凝和抗生素剂量相关的调整。这种基于病例的模拟是随着患者临床状况的变化而进行的,并且是根据患者的具体需求和相应机构的可用资源,在对该患者进行护理过程中逐步做出的决策。